Adiponectin gene variants and the risk of coronary heart disease: A 16-year longitudinal study

European Journal of Endocrinology

Volumn 171, Issue 1, 2014, Pages 107-115

  Cheung, Chloe Y Y ^a   Hui, Elaine Y L ^a   Cheung, Bernard M Y ^a   Woo, Y C ^a   Xu, Aimin ^a   Fong, Carol H Y ^a   Ong, K L ^a,c   Yeung, C Y ^a   Janus, Edward D ^d   Tse, Hung Fat ^a   Sham, Pak C ^a,b   Lam, Karen S L ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADIPOQ GENE; ADULT; AGE; ALLELE; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHINESE; CLINICAL STUDY; COHORT ANALYSIS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GENE; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HAZARD RATIO; HOMEOSTASIS; HUMAN; INCIDENCE; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PATHOGENESIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADULT; CORONARY ARTERY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84903534877     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-0079     Document Type: Article

References (33)

1. Hui X, Lam KS, Vanhoutte PM & Xu A. Adiponectin and cardiovascular health: an update. British Journal of Pharmacology 2012 165 574-590. (doi:10.1111/j.1476-5381.2011.01395.x)
2. Arita Y, Kihara S, Ouchi N, TakahashiM, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications 1999 257 79-83. (doi:10.1006/bbrc.1999.0255)
3. Lam KS & Xu A. Adiponectin: protection of the endothelium. Current Diabetes Reports 2005 5 254-259. (doi:10.1007/s11892-005-0019-y)
4. Shargorodsky M, Boaz M, Goldberg Y, Matas Z, Gavish D, Fux A & Wolfson N. Adiponectin and vascular properties in obese patients: is it a novel biomarker of early atherosclerosis? International Journal of Obesity 2009 33 553-558. (doi:10.1038/ijo.2009.37)
5. Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, Uchida S, Ito Y, Takakuwa K, Matsui J et al. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. Journal of Biological Chemistry 2003 278 2461-2468. (doi:10.1074/jbc.M209033200)
6. Koenig W, Khuseyinova N, Baumert J, Meisinger C & Lowel H. Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany. Journal of the American College of Cardiology 2006 48 1369-1377. (doi:10.1016/j.jacc.2006.06.053)
7. Poehls J, Wassel CL, Harris TB, Havel PJ, Swarbrick MM, Cummings SR, Newman AB, Satterfield S & Kanaya AM. Association of adiponectin with mortality in older adults: the Health, Aging, and Body Composition Study. Diabetologia 2009 52 591-595. (doi:10.1007/s00125-009-1261-7)
8. Wilson SR, Sabatine MS, Wiviott SD, Ray KK, De Lemos JA, Zhou S, Rifai N, Cannon CP & Morrow DA. Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22). American Heart Journal 2011 161 1147-1155.e1141. (doi:10.1016/j.ahj.2011.02.014)
9. Qi L, Li T, Rimm E, Zhang C, Rifai N, Hunter D, Doria A & Hu FB. The C276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men. Diabetes 2005 54 1607-1610. (doi:10.2337/diabetes.54.5.1607)
10. Gable DR, Matin J, Whittall R, Cakmak H, Li KW, Cooper J, Miller GJ & Humphries SE. Common adiponectin gene variants show different effects on risk of cardiovascular disease and type 2 diabetes in European subjects. Annals of Human Genetics 2007 71 453-466. (doi:10.1111/j.1469-1809.2006.00340.x)
11. Pischon T, Pai JK, Manson JE, Hu FB, Rexrode KM, Hunter D & Rimm EB. Single nucleotide polymorphisms at the adiponectin locus and risk of coronary heart disease in men and women. Obesity 2007 15 2051-2060. (doi:10.1038/oby. 2007.244)
12. Janus ED. Epidemiology of cardiovascular risk factors in Hong Kong. Clinical and Experimental Pharmacology and Physiology 1997 24 987-988. (doi:10.1111/j.1440-1681.1997.tb02736.x)
13. Chow WS, Tso AW, Xu A, Yuen MM, Fong CH, Lam TH, Lo SV, Tse HF, Woo YC, Yeung CY et al. Elevated circulating adipocyte-fatty acid binding protein levels predict incident cardiovascular events in a community-based cohort: a 12-year prospective study. Journal of the American Heart Association 2013 2 e004176. (doi:10.1161/JAHA.112.004176)
14. Cheung BM, Wat NM, Man YB, Tam S, Thomas GN, Leung GM, Cheng CH, Woo J, Janus ED, Lau CP et al. Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study. Diabetes Care 2007 30 1430-1436. (doi:10.2337/dc06-1820)
15. Alberti KG & Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine 1998 15 539-553. (doi:10.1002/(SICI)1096-9136(199807)15:7!539::AID-DIA668O3.0. CO;2-S)
16. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Journal of the American Medical Association 2001 285 2486-2497. (doi:10.1001/jama.285.19.2486)
17. Xu A, Chan KW, Hoo RL, Wang Y, Tan KC, Zhang J, Chen B, Lam MC, Tse C, Cooper GJ et al. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. Journal of Biological Chemistry 2005 280 18073-18080. (doi:10.1074/jbc.M414231200)
18. Barth N, Langmann T, Scholmerich J, Schmitz G & Schaffler A. Identification of regulatory elements in the human adipose most abundant gene transcript-1 (apM-1) promoter: role of SP1/SP3 and TNF-A as regulatory pathways. Diabetologia 2002 45 1425-1433. (doi:10.1007/s00125-002-0895-5)
19. Zhang D, Ma J, Brismar K, Efendic S & Gu HF. A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study. Journal of Diabetes and its Complications 2009 23 265-272. (doi:10.1016/j.jdiacomp.2008.05.004)
20. Laumen H, Saningong AD, Heid IM, Hess J, Herder C, Claussnitzer M, Baumert J, Lamina C, Rathmann W, Sedlmeier EM et al. Functional characterization of promoter variants of the adiponectin gene complemented by epidemiological data. Diabetes 2009 58 984-991. (doi:10.2337/db07-1646)
21. Filippi E, Sentinelli F, Romeo S, Arca M, Berni A, Tiberti C, Verrienti A, Fanelli M, Fallarino M, Sorropago G et al. The adiponectin gene SNP+ 276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age
22. Ong KL, Li M, Tso AW, Xu A, Cherny SS, Sham PC, Tse HF, Lam TH, Cheung BM & Lam KS. Association of genetic variants in the adiponectin gene with adiponectin level and hypertension in Hong Kong Chinese. European Journal of Endocrinology 2010 163 251-257. (doi:10.1530/EJE-10-0251)
23. Antonopoulos AS, Tousoulis D, Antoniades C, Miliou A, Hatzis G, Papageorgiou N, Demosthenous M, Tentolouris C & Stefanadis C. Genetic variability on adiponectin gene affects myocardial infarction risk: the role of endothelial dysfunction. International Journal of Cardiology 2012 168 326-330. (doi:10.1016/j.ijcard.2012.09.053)
24. Gui MH, Li X, Jiang SF, Gao J, Lu DR & Gao X. Association of the adiponectin gene rs1501299 G>T variant, serum adiponectin levels, and the risk of coronary artery disease in a Chinese population. Diabetes Research and Clinical Practice 2012 97 499-504. (doi:10.1016/j.diabres.2012.05.011)
25. Bottner A, Kratzsch J, Muller G, Kapellen TM, Bluher S, Keller E, Bluher M & Kiess W. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. Journal of Clinical Endocrinology and Metabolism 2004 89 4053-4061. (doi:10.1210/jc.2004- 0303)
26. Purcell S, Cherny SS & Sham PC. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003 19 149-150. (doi:10.1093/bioinformatics/19.1.149)
27. Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, Yamauchi T, Otabe S, Okada T, Eto K et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002 51 536-540. (doi:10.2337/diabetes.51.2.536)
28. Ramya K, Ayyappa KA, Ghosh S, Mohan V & Radha V. Genetic association of ADIPOQ gene variants with type 2 diabetes, obesity and serum adiponectin levels in south Indian population. Gene 2013 532 253-262. (doi:10.1016/j.gene. 2013.09.012)
29. Arikoglu H, Ozdemir H, Kaya DE, Ipekci SH, Arslan A, Kayis SA & Gonen MS. The adiponectin variants contribute to the genetic background of type 2 diabetes in Turkish population. Gene 2014 534 10-16. (doi:10.1016/j.gene.2013. 10.039)
30. Matsuzawa Y, Funahashi T, Kihara S & Shimomura I. Adiponectin and metabolic syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 29-33. (doi:10.1161/01.ATV.0000099786.99623.EF)
31. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002 51 2734-2741. (doi:10.2337/diabetes.51.9.2734)
32. Cooper DN. Functional intronic polymorphisms: buried treasure awaiting discovery within our genes. Human Genomics 2010 4 284-288. (doi:10.1186/1479- 7364-4-5-284)
33. Majewski J & Ott J. Distribution and characterization of regulatory elements in the human genome. Genome Research 2002 12 1827-1836. (doi:10.1101/gr.606402)